Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2017. Start Trial.
Date Value
October 09, 2026 129.05
October 08, 2026 129.78
October 07, 2026 128.21
October 06, 2026 134.50
October 05, 2026 138.18
October 02, 2026 136.30
October 01, 2026 136.58
September 30, 2026 141.16
September 29, 2026 141.46
September 28, 2026 142.67
September 25, 2026 143.23
September 24, 2026 145.20
September 23, 2026 142.59
September 22, 2026 151.43
September 21, 2026 154.24
September 18, 2026 155.03
September 17, 2026 154.64
September 16, 2026 152.53
September 15, 2026 153.57
September 14, 2026 151.97
September 11, 2026 151.29
September 10, 2026 154.92
September 09, 2026 156.43
September 08, 2026 158.96
September 04, 2026 159.52
Date Value
September 03, 2026 161.38
September 02, 2026 156.83
September 01, 2026 155.25
August 31, 2026 160.17
August 28, 2026 158.06
August 27, 2026 160.90
August 26, 2026 162.89
August 25, 2026 163.93
August 24, 2026 164.13
August 21, 2026 162.16
August 20, 2026 159.21
August 19, 2026 166.43
August 18, 2026 165.67
August 17, 2026 167.64
August 14, 2026 164.21
August 13, 2026 157.33
August 12, 2026 160.03
August 11, 2026 162.53
August 10, 2026 155.79
August 07, 2026 158.99
August 06, 2026 153.82
August 05, 2026 154.44
August 04, 2026 154.83
August 03, 2026 150.70
July 31, 2026 149.86

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 19.19
Anika Therapeutics, Inc. 1.909
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.203

Price to Book Value Related Metrics